According to a press release by the U.S. Securities and Exchange Commission on February 1st, on January 31st, Ispire Technology, Inc. (hereinafter referred to as the "Company") signed a letter of intent and term sheet (hereinafter referred to as the "Term Sheet") with Touch Point Worldwide Inc., also known as Berify (hereinafter referred to as "Berify"), a technology company specializing in linking physical products to the digital world, digital interaction, and brand protection.
According to the terms outlined in the agreement, all parties intend to establish a new joint venture company known as "NewCo" in the state of Delaware. Ispire and Berify will hold 50% ownership each in NewCo. Ispire will invest a total of $10 million in NewCo, which will be utilized to support the pre-market tobacco product application submitted to the US Food and Drug Administration, as well as for software development.
Berify agrees to an exclusive period where its intellectual property related to products used for inhaling, vaporizing, atomizing, or heating nicotine and/or tobacco, as well as any packaging related to its product authentication system, blockchain technology for product identification, connected device platforms (such as applications and dashboards), and smart chips or tags (or similar technologies) (referred to as "Berify licensed assets") will be exclusively held by Berify. During this period, Berify agrees not to engage in any discussions or negotiations related to the acquisition or licensing of Berify licensed assets without prior approval from the company. Upon the finalization of the agreement, the company agrees to issue warrants to Berify for the purchase of 111,111 shares of the company's common stock at an exercise price of $9.00 per share.
The clause states that negotiations should be conducted in good faith, with the aim of implementing the provisions outlined in the term sheet into a final agreement. The signing of the final agreement is subject to various uncertainties, including the completion of customary due diligence by all parties, negotiations on the final agreement, approval by the respective boards of directors, and the fulfillment of other customary closing conditions, including but not limited to obtaining any necessary government and third-party approvals. There is no guarantee that the final agreement will be signed in accordance with the provisions set forth in the term sheet or in any other manner. If the final agreement is not signed by April 1, 2024 (referred to as the "deadline" hereafter), the term sheet shall be considered void, and all parties will be released from the obligations contained therein. The deadline may be extended at any time by mutual agreement in writing.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
